Media Library

Dr. Edward Garon speaks about how differences in patient populations with lung cancer can make it difficult to interpret and act on data.
Dr. Edward Garon shares an anecdote about an interesting NSCLC case from his practice.
Dr. Edward Garon explains how he discusses immunotherapies with patients.
Dr. Edward Garon describes how staff at his practice interacts with patients.
Dr. Edward Garon believes it's important to recognize that agents without efficacy are not beneficial to the patient despite low toxicity.
Dianna Shafer talks about the testing protocol when examining patients’ bones and what they prescribe to ensure their patients’ bone health is being addressed.
Dianna Shafer talks about when testing shows metastasis, and how they use Xgeva when a patient is in this state.
Pam Skurkay, Dianna Shafer, and Angela Hunter discuss the rates of incidences of this issue as well as the benefits of using Xgeva, including a better quality of life for patients.
Pam Skurkay discusses the comparison rate of skeletal related events in bisphosphonates versus Xgeva.
Pam Skurkay, Dianna Shafer, and Angela Hunter talk about how technology and new medicines are not only helpful for patients, but assists researchers and providers in finding more information including locating clinical trials.
Page 3 of 6
Results 21 - 30 of 54